Conformis, Inc. (CFMS)
Conformis, Inc. operates in the Medical - Devices industry of the Healthcare sector, headquartered in Billerica, MA, US. The stock last traded at $2.27, up 0.44% on the session, giving a market capitalisation of $17.9M. On trailing twelve-month figures it carries a trailing P/E of -0.32, a net margin of -81.3%. Its beta of 1.42 implies it has historically moved more than the broad market.
Conformis, Inc., established in Billerica, Massachusetts in 2004, functions as a medical technology enterprise that designs, produces, and commercializes custom-fit medical devices and surgical instruments. Their product portfolio encompasses a variety of personalized knee replacement systems, including iUni and iDuo for addressing unicompartmental or bicompartmental knee osteoarthritis, the iTotal CR for cruciate-retaining total knee procedures, the iTotal PS for posterior-stabilized total knee replacements, as well as the iTotal Identity and Identity Imprint lines. Additionally, the company offers hip replacement options like the Conformis Hip System and Cordera products, and provides iJigs, which are personalized, single-use surgical guides. Conformis distributes these specialized solutions to orthopedic surgeons, hospitals, and other medical facilities through its dedicated sales force, independent representatives, and distributors, serving markets across the United States, Germany, the United Kingdom, Austria, Ireland, Switzerland, Spain, Portugal, the Netherlands, Belgium, the Dutch Antilles, Suriname, Australia, the United Arab Emirates, Oman, Italy, Poland, and other global regions.
Conformis, Inc. is most often compared with the following Healthcare names: